Benlysta (Belimumab) is a biologic medicine that is used to treat lupus. It works by suppressing part of the body's immune system.
Benlysta inhibits a type of signalling protein (called a cytokine) that works to activate a type of white blood cell called the B-cell.
Benlysta is given as an intravenous infusion (IV) by a trained nurse in a clinic.
The manufacturer of Benlysta offers a support program to Canadian patients that are prescribed the medication:Patient support program enrolment forms
Important Tests and Risks
Drug Identification Number (DIN)